North Park Group: Buy Small EBITDA Firms, Hold Forever
Learn Ryan Sullivan's proven strategy at North Park Group: buy $1m EBITDA companies at 4x multiples, leverage SBA financing, and achieve 25% annual returns.


North Park Group's buy box is tightly defined: The target produces ~$1m of EBITDA, typically owned by a retiring founder in manufacturing or industrial services. Each business comes with its real estate, allowing for 25-year SBA financing. The total all-in transaction averages about $6m, including ~$1.5m for the building. Deals are structured at 50% equity and 50% debt, resulting in about $3m of investor capital and $3m of bank financing. They bring in an operating partner to run the company and hold it for the long term, targeting 25% annual returns on equity without exits.

Deal flow begins with a disciplined funnel. Opportunities arrive from Axial, Generational Equity, and buy-side brokers compensated at ~$5k/month plus a success fee. Out of ~200 conversations, ~20 advance to IOI, and 5-8 progress to signed LOIs each year. The close rate is about 25% on LOIs. Half of lost deals don't transact, and the remainder fall away on size, fit, or valuation.

A case study is Arcadia Glasshouse in Ohio, acquired in January 2025. The company produced ~$800k of EBITDA and sold for ~4x, or $3.2m, plus $1.8m for the building. Total capitalization reached $5m, with $2.8m of equity and $2.2m of blended SBA 7a and 504 debt. Since closing, Arcadia has reinvested in equipment, hired additional staff, and expanded production capacity by 15%.

Operating partners hold real equity in the GP and share management fees across all portfolio companies. Conservative 50% leverage, combined with real estate collateral, limits personal guarantee risk and allows strong cash flow coverage and steady distributions.
More recent episodes

Holding All-Equity Deals Forever
Logan Walters of Forge Equity discusses indefinite hold periods in private equity, dividend strategies, and case studies from electronics recycling to equipment rentals.

From Venture Capital to Independent Sponsor
Christian Seale discusses why buying healthcare businesses beats building from scratch, Mexico as a healthcare innovation lab, and Miami's rise as an entrepreneurial hub.

Promoted from Associate to MD at Independent Sponsor Firm
Jimmy Watson shares his journey from FP&A at Raytheon to Managing Director at Clavis Capital Partners, discussing independent sponsorship and navigating the lower middle-market.